NVRO Nevro Corp 
Health Care [ 5/12 ] | Health Care Equipment & Supplies [ 32/74 ]
NYSE | Common Stock
- Price
- $5.84Increased by 0.00%
- Dollar volume (20D)
- 7.14 M
- ADR%
- 0.46
- Earnings report date
- May 5, 2025
- Shares float
- 34.23 M
- Shares short
- 1.69 M [4.94%]
- Shares outstanding
- 38.37 M
- Market cap
- 224.09 M
- Beta
- 0.82
- Price/earnings
- N/A
- 20D range
- 5.73 5.86
- 50D range
- 4.63 5.86
- 200D range
- 3.17 10.37
Nevro Corp., a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally.
The company provides HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic back and leg pain through paresthesia-free 10 kHz therapy, as well as offers Senza II and Senza Omnia SCS systems.
It also offers Senza HFX iQ platform that includes HFX iQ implantable pulse generator, HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system.
In addition, the company provides HFX AdaptivAI, a pain management platform that powers the HFX iQ SCS system, as well as surpass surgical and percutaneous leads.
It sells its products through its direct sales force, and a network of sales agents and independent distributors.
The company was incorporated in 2006 and is based in Redwood City, California.
- Quarterly earnings
- Annual earnings
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Mar 4, 25 | -0.65 Decreased by -158.36% | -0.67 Increased by +3.60% |
| Nov 11, 24 | -0.41 Increased by +36.92% | -0.81 Increased by +49.38% |
| Aug 6, 24 | -0.53 Increased by +23.19% | -0.68 Increased by +22.06% |
| May 7, 24 | -0.58 Increased by +40.82% | -1.05 Increased by +44.76% |
| Feb 21, 24 | -0.25 Increased by +53.70% | -0.49 Increased by +48.98% |
| Nov 1, 23 | -0.65 Decreased by -129.28% | -0.77 Increased by +15.58% |
| Aug 1, 23 | -0.69 Increased by +2.82% | -0.69 |
| Apr 26, 23 | -0.98 Increased by 0.00% | -1.04 Increased by +5.77% |
- Quarterly financials
- Annual financials
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 24 | 105.55 M Decreased by -9.15% | -53.11 M Decreased by -491.37% | Decreased by -50.32% Decreased by -550.92% |
| Sep 30, 24 | 96.91 M Decreased by -6.69% | -15.34 M Increased by +34.65% | Decreased by -15.83% Increased by +29.96% |
| Jun 30, 24 | 104.16 M Decreased by -4.27% | -19.57 M Increased by +20.83% | Decreased by -18.79% Increased by +17.29% |
| Mar 31, 24 | 101.90 M Increased by +5.78% | -25.41 M Increased by +27.46% | Decreased by -24.94% Increased by +31.43% |
| Dec 31, 23 | 116.18 M Increased by +2.05% | -8.98 M Increased by +53.20% | Decreased by -7.73% Increased by +54.14% |
| Sep 30, 23 | 103.86 M Increased by +3.38% | -23.48 M Decreased by -128.81% | Decreased by -22.61% Decreased by -127.86% |
| Jun 30, 23 | 108.81 M Increased by +4.41% | -24.72 M Increased by +1.06% | Decreased by -22.72% Increased by +5.24% |
| Mar 31, 23 | 96.33 M Increased by +9.66% | -35.03 M Decreased by -2.05% | Decreased by -36.36% Increased by +6.94% |
This website uses cookies. To learn more about cookies, please see our privacy policy .